EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Systemic and Retinal Protective Effects of Butyrate in Early Type 2 Diabetes via Gut Microbiota–Lipid Metabolism Interaction

Haijun Gong iD, Haoyu Zuo, Keling Wu, Xinbo Gao, Yuqing Lan, Ling Zhao

Nutrients · 18.07.2025 · 17 (14) · 2363

DOI: 10.3390/nu17142363 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, online erschienen am 18.07.2025. Verfasst von Haijun Gong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Department of Ophthalmology, Sun Yat-sen Memorial Hospital, S…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Lipid Metabolism, Diabetes Mellitus, Type 2, Diabetic Retinopathy. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Project of Administration of Traditional Chinese Medicine of Guangdong Province of China, National Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Early neurovascular unit (NVU) impairment plays a critical role in the pathogenesis of diabetic retinopathy (DR), often preceding clinically detectable changes. Butyrate, a short-chain fatty acid (SCFA) derived from gut microbiota, has shown promising metabolic and anti-inflammatory effects.

Methods

This study investigated the protective potential of oral butyrate supplementation in a mouse model of early type 2 diabetes mellitus (T2DM) induced by a high-fat diet and streptozotocin. Mice (C57BL/6J) received sodium butyrate (5 g/L in drinking water) for 12 weeks. Retinal NVU integrity was assessed using widefield swept-source optical coherence tomography angiography (WF SS-OCTA), alongside evaluations of systemic glucose and lipid metabolism, hepatic steatosis, visual function, and gut microbiota composition via 16S rRNA sequencing.

Results

Butyrate supplementation significantly reduced body weight, fasting glucose, serum cholesterol, and hepatic lipid accumulation. Microbiome analysis demonstrated a partial reversal of gut dysbiosis, characterized by increased SCFA-producing taxa (Ruminococcaceae, Oscillibacter, Lachnospiraceae) and decreased pro-inflammatory, lipid-metabolism-related genera (Rikenella, Ileibacterium). KEGG pathway analysis further revealed enrichment in microbial lipid metabolism functions (fabG, ABC.CD.A, and transketolase). Retinal vascular and neurodegenerative alterations—including reduced vessel density and retinal thinning—were markedly attenuated by butyrate, as revealed by WF SS-OCTA. OKN testing indicated partial improvement in visual function, despite unchanged ERG amplitudes.

Conclusions

Butyrate supplementation mitigates early NVU damage in the diabetic retina by improving glucose and lipid metabolism and partially restoring gut microbial balance. This study also underscores the utility of WF SS-OCTA as a powerful noninvasive tool for detecting early neurovascular changes in DR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeLipid MetabolismDiabetes Mellitus, Type 2Diabetic RetinopathyRetinaButyric AcidButyratesAnimalsMice, Inbred C57BLMiceMaleDiabetes Mellitus, ExperimentalDiet, High-FatBlood GlucoseDysbiosis

Stichwörter der Autor:innen

WF SS-OCTAbutyratediabetic retinopathygut microbiotalipid metabolism

Substanzen

Butyric AcidButyratesBlood Glucose

Autor:innen und Institutionen

  • Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Department of Ophthalmology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China.
  • State Key Laboratory of Ophthalmology, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 510060, China.
  • Guangdong Provincial Key Laboratory of Brain Function and Disease, Guangzhou 510080, China.

ORCID-Profile: Haijun Gong

Förderung

  • Project of Administration of Traditional Chinese Medicine of Guangdong Province of China
  • National Natural Science Foundation of China
  • Guangdong Basic and Applied Basic Research Foundation
  • National Key Research and Development Program of China
  • Guangzhou City-University Joint Foundation
  • The Science and Technology Planning Project of Guangdong Province
  • Medical Scientific Research Foundation of Guangdong Province of China
  • Pearl River Talents Program-Local Innovative and Research Teams

Zitieren

APA

Gong, H., Zuo, H., Wu, K., Gao, X., Lan, Y., & Zhao, L. (2025). Systemic and Retinal Protective Effects of Butyrate in Early Type 2 Diabetes via Gut Microbiota–Lipid Metabolism Interaction. Nutrients, 17(14), 2363. https://doi.org/10.3390/nu17142363

Vancouver

Gong H, Zuo H, Wu K, Gao X, Lan Y, Zhao L. Systemic and Retinal Protective Effects of Butyrate in Early Type 2 Diabetes via Gut Microbiota–Lipid Metabolism Interaction. Nutrients. 2025;17(14):2363. doi:10.3390/nu17142363

BibTeX
@article{Gong2025,
  author = {Gong, Haijun and Zuo, Haoyu and Wu, Keling and Gao, Xinbo and Lan, Yuqing and Zhao, Ling},
  title = {Systemic and Retinal Protective Effects of Butyrate in Early Type 2 Diabetes via Gut Microbiota–Lipid Metabolism Interaction},
  journal = {Nutrients},
  year = {2025},
  volume = {17},
  number = {14},
  pages = {2363},
  doi = {10.3390/nu17142363}
}
Kostenlos starten →